DRUG_NAME,STRUCT_ID,TARGET_NAME,TARGET_CLASS,ACCESSION,GENE,SWISSPROT,ACT_VALUE,ACT_UNIT,ACT_TYPE,ACT_COMMENT,ACT_SOURCE,RELATION,MOA,MOA_SOURCE,ACT_SOURCE_URL,MOA_SOURCE_URL,ACTION_TYPE,TDL,ORGANISM
astemizole,249,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,9.0458,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
sertindole,2435,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.57,,IC50,Inhibition of human cloned ERG expressed in CHO cells assessed as inhibition of potassium channel current by automated patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,Tclin,Homo sapiens
benperidol,312,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.47,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
dofetilide,942,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.19,,Ki,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells by SPA,CHEMBL,=,1.0,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473,BLOCKER,Tclin,Homo sapiens
cisapride,660,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.19,,IC50,Inhibition of human ERG in MCF7 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,Tclin,Homo sapiens
ibutilide,1412,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.0,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL533,,BLOCKER,Tclin,Homo sapiens
verapamil,2815,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.0,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,Tclin,Homo sapiens
clemastine,671,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.9208,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
lidoflazine,1580,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.8,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92870,,,Tclin,Homo sapiens
tolterodine,2705,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.77,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,,,Tclin,Homo sapiens
pimozide,2172,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.7447,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
haloperidol,1353,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.5,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
droperidol,966,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.49,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108,,,Tclin,Homo sapiens
febuxostat,1137,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.44,,EC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
benzamycin,3875,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.41,,IC50,Inhibition of human ERG expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL532,,,Tclin,Homo sapiens
erythromycin,1048,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.41,,IC50,Inhibition of human ERG expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL532,,,Tclin,Homo sapiens
terfenadine,2600,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.2518,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
benzethonium,3018,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.051098239,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
ifenprodil,1419,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.0,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,Tclin,Homo sapiens
thioridazine,2637,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.0,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
azelastine,271,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.0,,IC50,Displacement of labeled dofetilide human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL639,,,Tclin,Homo sapiens
ketanserin,1524,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.97,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
ziprasidone,2865,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.92,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
pergolide,2105,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.92,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,Tclin,Homo sapiens
domperidone,945,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.7905,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
risperidone,2389,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.7878,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
loratadine,1605,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.77,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
clomifene,700,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.7447,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
olanzapine,1982,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.74,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
mibefradil,1797,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.72,,Ki,Binding affinity at hERG expressed in HEK293 cells by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45816,,,Tclin,Homo sapiens
amsacrine,203,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.68,,IC50,Inhibition of human ERG potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43,,,Tclin,Homo sapiens
clozapine,722,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.6,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
ebastine,977,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.55,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
dronedarone,4112,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.5,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL184412,,,Tclin,Homo sapiens
mesoridazine,1712,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.5,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088,,,Tclin,Homo sapiens
pethidine,1690,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.49,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607,,,Tclin,Homo sapiens
quinidine,2346,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.49,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,,,Tclin,Homo sapiens
carvedilol,522,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.46,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,,,Tclin,Homo sapiens
mizolastine,1824,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.4559,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
azimilide,274,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.4,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL123558,,,Tclin,Homo sapiens
flunarizine,1200,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.304255725,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
terodiline,2603,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.3,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL363295,,,Tclin,Homo sapiens
sunitinib,2544,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.3,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,Tclin,Homo sapiens
bepridil,342,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.26,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
doxazosin,954,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.23,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
clebopride,670,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.22,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,Tclin,Homo sapiens
aripiprazole,242,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.22,,Ki,Displacement of [3H]dofetilide from human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,Tclin,Homo sapiens
fluoxetine,1209,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.1549,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
propafenone,2291,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.0969,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
ondansetron,1992,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.0915,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
budipine,420,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.07,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL334491,,,Tclin,Homo sapiens
brompheniramine,408,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.05,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL811,,,Tclin,Homo sapiens
tacrolimus,2552,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.0,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
mepyramine,2331,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.96,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511,,,Tclin,Homo sapiens
vesnarinone,2817,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.96,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17423,,,Tclin,Homo sapiens
chlorphenamine,616,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.96,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,,,Tclin,Homo sapiens
protriptyline,2320,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.9281,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
imipramine,1427,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.9,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
ceritinib,4866,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.9,,IC50,Inhibition of human ERG by dofetilide binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,Tclin,Homo sapiens
paliperidone palmitate,4498,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.89,,IC50,Inhibition of human ERG channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107360,,,Tclin,Homo sapiens
paliperidone,4137,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.89,,IC50,Inhibition of human ERG channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621,,,Tclin,Homo sapiens
desipramine,812,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.86,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
chlorpromazine,621,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.83,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
arsenic trioxide,244,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.824,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
prochlorperazine,2274,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.819845441,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
prazosin,4209,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.8,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,Tclin,Homo sapiens
tamoxifen,2561,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.8,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,Tclin,Homo sapiens
betrixaban,5241,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.75,,Ki,Binding affinity to human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL512351,,,Tclin,Homo sapiens
fentanyl,1164,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.74,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,Tclin,Homo sapiens
ketoconazole,1527,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.72,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
donepezil,946,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.7,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,Tclin,Homo sapiens
atomoxetine,256,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.68,,IC50,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,,,Tclin,Homo sapiens
acetylmethadol,1729,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.66,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL170179,,,Tclin,Homo sapiens
levomethadyl acetate,1571,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.65999984741211,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1514,,,Tclin,Homo sapiens
alosetron,129,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.64,,IC50,Inhibition of human ERG expressed in HEK cells by patch clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1110,,,Tclin,Homo sapiens
fluspirilene,1222,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.64,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46516,,,Tclin,Homo sapiens
amodiaquine,186,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.62,,IC50,Inhibition of human cloned ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL682,,,Tclin,Homo sapiens
chloroquine,607,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.6,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
diphenhydramine,916,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.59,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL657,,,Tclin,Homo sapiens
rimonabant,4150,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.55,,IC50,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of potassium channel current after 5 mins by patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,,,Tclin,Homo sapiens
trazodone,2717,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.54,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
mitoxantrone,1821,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.532096053,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
clotrimazole,719,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.52,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,Tclin,Homo sapiens
sildenafil,2441,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.48,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,Tclin,Homo sapiens
perphenazine,2113,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.461665093,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
granisetron,1329,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.4283,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
flecainide,1176,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.41,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL652,,,Tclin,Homo sapiens
citalopram,663,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.4,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
buspirone,437,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.4,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,Tclin,Homo sapiens
fluphenazine,1212,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.330255545,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
mosapride,1848,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.32,,IC50,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL60889,,,Tclin,Homo sapiens
myrtecaine,3787,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.31554065,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
caffeine,463,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.31,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,Tclin,Homo sapiens
trifluoperazine,2740,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.292361705,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
mefloquine,1665,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.25,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
quetiapine,2337,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.24,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,Tclin,Homo sapiens
dolasetron,3931,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.2255,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
orphenadrine,1999,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.1739,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
sertraline,2436,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.166591497,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
papaverine,2056,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.14,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,Tclin,Homo sapiens
cocaine,723,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.14,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
halofantrine,1350,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.12,,Ki,Inhibition of human ERG expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1107,,,Tclin,Homo sapiens
perhexiline,2106,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.11,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75880,,,Tclin,Homo sapiens
buprenorphine,434,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.1,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142,,,Tclin,Homo sapiens
lumefantrine,1617,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.09,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38827,,,Tclin,Homo sapiens
lopinavir,1601,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.07,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL729,,,Tclin,Homo sapiens
paroxetine,2068,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.068313346,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens
cibenzoline,630,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.06,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87045,,,Tclin,Homo sapiens
methadone,1728,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.01,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL651,,,Tclin,Homo sapiens
ouabain,2004,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.0088,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
amiodarone,176,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.0,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL633,BLOCKER,Tclin,Homo sapiens
mexiletine,1794,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.0,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,,,Tclin,Homo sapiens
nifekalant,1923,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.0,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360861,,,Tclin,Homo sapiens
nitrendipine,1947,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.0,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL475534,,,Tclin,Homo sapiens
amitriptyline,180,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.0,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens
